Literature DB >> 12514115

Blockade of the apoptotic machinery by cyclosporin A redirects cell death toward necrosis in arterial endothelial cells: regulation by reactive oxygen species and cathepsin D.

Marc-André Raymond1, Luigina Mollica, Normand Vigneault, Anik Désormeaux, John S D Chan, Janos G Filep, Marie-Josée Hébert.   

Abstract

Blockade of the mitochondrial permeability transition pore (mPTP) by cyclosporin A (CsA) inhibits apoptosis in various cell types. However, use of CsA in humans is associated with damage to the arterial endothelium. We evaluated whether inhibition of the apoptotic machinery by CsA promotes other forms of cell death in arterial endothelial cells (EC). Exposure of human umbilical artery EC (HUAEC) to clinically relevant concentrations of CsA for up to 24 h was associated with a significant increase in necrotic features. We detected inhibition of apoptosis and a significant increase in necrosis in HUAEC exposed concomitantly to CsA and mitomycin C, a proapoptotic DNA damaging agent. We found that CsA-induced cell death is independent of caspase activation, p53 induction, and calcineurin inhibition. However, bongkrekic acid, another mPTP blocker, also increased necrosis in HUAEC. Dihydroethidium and acridine orange staining revealed increased intracellular production of reactive oxygen species (ROS) followed by lysosomal damage in HUAEC exposed to CsA. Hydroxyl radical and superoxide scavengers and inhibition of cathepsin D activity significantly attenuated CsA-induced EC death. These results suggest that inhibition of the apoptotic machinery by CsA in arterial EC favors development of a necrotic form of cell death regulated by ROS and secondary lysosomal damage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12514115     DOI: 10.1096/fj.02-0500fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

1.  Modest intracellular acidification suppresses death signaling in ouabain-treated cells.

Authors:  Olga A Akimova; Dimitri Pchejetski; Pavel Hamet; Sergei N Orlov
Journal:  Pflugers Arch       Date:  2005-07-29       Impact factor: 3.657

2.  Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells.

Authors:  Hemant Sarin
Journal:  Mol Clin Oncol       Date:  2015-12-16

Review 3.  Role of ROS and RNS Sources in Physiological and Pathological Conditions.

Authors:  Sergio Di Meo; Tanea T Reed; Paola Venditti; Victor Manuel Victor
Journal:  Oxid Med Cell Longev       Date:  2016-07-12       Impact factor: 6.543

4.  GSK-3beta promotes cell survival by modulating Bif-1-dependent autophagy and cell death.

Authors:  Jun Yang; Yoshinori Takahashi; Erdong Cheng; Jihong Liu; Paul F Terranova; Bin Zhao; J Brantley Thrasher; Hong-Gang Wang; Benyi Li
Journal:  J Cell Sci       Date:  2010-02-16       Impact factor: 5.285

5.  Blocking mitochondrial permeability transition prevents p53 mitochondrial translocation during skin tumor promotion.

Authors:  Jianfeng Liu; Daret K St Clair; Xin Gu; Yunfeng Zhao
Journal:  FEBS Lett       Date:  2008-03-20       Impact factor: 4.124

Review 6.  Oxygen free radicals and redox biology of organelles.

Authors:  Leni Moldovan; Nicanor I Moldovan
Journal:  Histochem Cell Biol       Date:  2004-09-25       Impact factor: 4.304

7.  Chymase-mediated intestinal epithelial permeability is regulated by a protease-activating receptor/matrix metalloproteinase-2-dependent mechanism.

Authors:  Katherine R Groschwitz; David Wu; Heather Osterfeld; Richard Ahrens; Simon P Hogan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-01-10       Impact factor: 4.052

8.  Genes of the mitochondrial apoptotic pathway in Mytilus galloprovincialis.

Authors:  Noelia Estévez-Calvar; Alejandro Romero; Antonio Figueras; Beatriz Novoa
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

9.  Role of Endothelial Cells in Myocardial Ischemia-Reperfusion Injury.

Authors:  Arun K Singhal; J David Symons; Sihem Boudina; Bharat Jaishy; Yan-Ting Shiu
Journal:  Vasc Dis Prev       Date:  2010
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.